An animal model for Charcot-Marie-Tooth disease type 4B1

Human Molecular Genetics

Volumn 14, Issue 23, 2005, Pages 3685-3695

  Bonneick, Sonja ^a   Boentert, Matthias ^b   Berger, Philipp ^a   Atanasoski, Suzana ^a   Mantei, Ned ^a   Wessig, Carsten ^c   Toyka, Klaus V ^c   Young, Peter ^b   Suter, Ueli ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF MÜNSTER   (Germany)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; MYELIN; MYOTUBULARIN RELATED PROTEIN 2; PHOSPHATASE; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOTECHNOLOGY; CHARCOT MARIE TOOTH DISEASE 4B1; CONTROLLED STUDY; DISEASE MODEL; ELECTROPHYSIOLOGY; EMBRYO; EMBRYONIC STEM CELL; EXON; GENE MUTATION; HEREDITARY MOTOR SENSORY NEUROPATHY; MOUSE; MYELIN SHEATH; NERVE FIBER; NONHUMAN; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; STOP CODON;

ALLELES; ANIMALS; CHARCOT-MARIE-TOOTH DISEASE; CODON, NONSENSE; DISEASE MODELS, ANIMAL; ELECTROPHYSIOLOGY; HOMOZYGOTE; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NEUROLOGIC MUTANTS; MYELIN SHEATH; PERIPHERAL NERVES; PROTEIN-TYROSINE-PHOSPHATASE; SEQUENCE DELETION;

ANIMALIA;

EID: 28744436993     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddi400     Document Type: Article

References (37)

1. Suter, U. and Snipes, G.J. (1995) Biology and genetics of hereditary motor and sensory neuropathies. Ann. Rev. Neurosci., 18, 45-75.
2. Suter, U. and Scherer, S.S. (2003) Disease mechanisms in inherited neuropathies. Nat. Rev. Neurosci., 4, 714-726.
3. Martini, R. (2000) Animal models for inherited peripheral neuropathies: chances to find treatment strategies? J. Neurosci. Res., 61, 244-250.
4. Lewis, R.A., Sumner, A.J. and Shy, M.E. (2000) Electrophysiological features of inherited demyelinating neuropathies: A reappraisal in the era of molecular diagnosis. Muscle Nerve, 23, 1472-1487.
5. Zielasek, J., Martini, R. and Toyka, K.V. (1996) Functional abnormalities in PO-deficient mice resemble human hereditary neuropathies linked to PO gene mutations. Muscle Nerve, 19, 946-952.
6. Bolino, A., Muglia, M., Conforti, F.L., LeGuern, E., Salih, M.A., Georgiou, D.M., Christodoulou, K., Hausmanowa-Petrusewicz, L, Mandich, P., Schenone, A. et al. (2000) Charcot-Marie-Tooth type 4B is caused by mutations in the gene encoding myotubularin-related protein-2. Nat. Genet., 25, 17-19.
7. Houlden, H., King, R.H., Wood, N.W., Thomas, P.K. and Reilly, M.M. (2001) Mutations in the 5′ region of the myotubularin-related protein 2 (MTMR2) gene in autosomal recessive hereditary neuropathy with focally folded myelin. Brain, 124, 907-915.
8. Nelis, E., Erdem, S., Tan, E., Lofgren, A., Ceuterick, C., De Jonghe, P., Van Broeckhoven, C., Timmerman, V. and Topaloglu, H. (2002) A novel homozygous missense mutation in the myotubularin-related protein 2 gene associated with recessive Charcot-Marie-Tooth disease with irregularly folded myelin sheaths. Neuromuscul. Disord., 12, 869-873.
9. Kochanski, A., Drac, H., Jedrzejowska, H. and Hausmanowa-Petrusewicz, I. (2003) Focally folded myelin in Charcot-Marie-Tooth type 1B disease is associated with Asn131Lys mutation in myelin protein zero gene: Short report. Ear. J Neurol., 10, 547-549.
10. Fabrizi, G.M., Taioli, F., Cavallaro, T., Rigatelli, F., Simonati, A., Mariani, G., Perrone, P. and Rizzuto, N. (2000) Focally folded myelin in Charcot-Marie-Tooth neuropathy type 1B with Ser49Leu in the myelin protein zero. Acta Neuropathol. (Berl.), 100, 299-304.
11. Berger, P., Bonneick, S., Willi, S., Wymann, M. and Suter, U. (2002) Loss of phosphatase activity in myotubularin-related protein 2 is associated with Charcot-Marie-Tooth disease type 4131. Hum. Mol. Genet., 11, 1569-1579.
12. Bolino, A., Marigo, V., Ferrera, F., Loader, J., Romio, L., Leoni, A., Di Duca, M., Cinti, R., Cecchi, C., Feltri, M.L. et al. (2002) Molecular characterization and expression analysis of Mtmr2, mouse homologue of MTMR2, the myotubularin-related 2 gene, mutated in CMT4B. Gene, 283, 17-26.
13. Bolino, A., Bolis, A., Previtali, S.C., Dina, G., Bussim, S., Dati, G., Amadio, S., Del Carro, U., Mruk, D.D., Feltri, M.L. et al. (2004) Disruption of Mtmr2 produces CMT4B1 -like neuropathy with myelin outfolding and impaired spermatogenesis. J Cell Biol., 167, 711-721.
14. Laporte, J., Bedez, F., Bolino, A. and Mandel, J.L. (2003) Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases. Hum. Mol. Genet., 12 (Spec no. 2), R285-R292.
15. Berger, P., Schaffitzel, C., Berger, I, Ban, N. and Suter, U. (2003) Membrane association of myotubularin-related protein 2 is mediated by a pleckstrin homology-GRAM domain and a coiled-coil dimerization module. Proc. Natl Acad. Sci. USA, 100, 12177-12182.
16. Previtali, S.C., Zerega, B., Sherman, D.L., Brophy, P.J., Dina, G., King, R.H., Salih, M.M., Feltri, L., Quattrini, A., Ravazzolo, R. et al. (2003) Myotubularin-related 2 protein phosphatase and neurofilament light chain protein, both mutated in CMT neuropathies, interact in peripheral nerve. Hum. Mol. Genet., 12, 1713-1723.
17. Azzedine, H., Bolino, A., Taieb, T., Birouk, N., Di Duca, M., Bouhouche, A., Benamou, S., Mrabet, A., Hammadouche, T., Chkili, T. et al. (2003) Mutations in MTMR 13, a new pseudophosphatase homologue of MTMR2 and Sbfl, in two families with an autosomal recessive demyelinating form of Charcot-Marie-Tooth disease associated with early-onset glaucoma. Am. J Hum. Genet., 72, 1141-1153.
18. Senderek, J., Bergmann, C., Weber, S., Ketelsen, U.P., Schorle, H., Rudnik-Schonebom, S., Buttner, R., Buchheim, E. and Zerres, K. (2003) Mutation of the SBF2 gene, encoding a novel member of the myotubularin family, in Charcot-Marie-Tooth neuropathy type 4B2/1lp15. Hum. Mol. Genet., 12, 349-356.
19. Nandurkar, H.H., Layton, M., Laporte, J., Selan, C., Corcoran, L., Caldwell, K.K., Mochizuki, Y., Majerus, P.W. and Mitchell, C.A. (2003) Identification of myotubularin as the lipid phosphatase catalytic subunit associated with the 3-phosphatase adapter protein, 3-PAP. Proc. Natl Acad. Sci. USA, 100, 8660-8665.
20. Mochizuki, Y. and Majerus, P.W. (2003) Characterization of myotubularin-related protein 7 and its binding partner, myotubularin-related protein 9. Proc. Natl Acad. Sci. USA, 100, 9768-9773.
21. Kim, S.A., Vacratsis, P.O., Firestein, R., Cleary, M.L. and Dixon, J.E. (2003) Regulation of myotubularin-related (MTMR)2 phosphatidylinositol phosphatase by MTMR5, a catalytically inactive phosphatase. Proc. Natl Acad. Sci. USA, 100, 4492-4497.
22. Robinson, F.L. and Dixon, J.E. (2005) The phosphoinositide 3-phosphatase MTMR2 associates with MTMR13, a novel membrane-associated pseudophosphatase also mutated in type 4B Charcot-Marie-Tooth disease. J Biol. Chem., 280, 31699-31707.
23. Walker, D.M., Urbe, S., Dove, S.K., Tenza, D., Raposo, G. and Clague, M.J. (2001) Characterization of MTMR3, an inositol lipid 3-phosphatase with novel substrate specificity. Carr. Biol., 11, 1600-1605.
24. Schaletzky, J., Dove, S.K., Short, B., Lorenzo, O., Clague, M.J. and Barr, F.A. (2003) Phosphatidylinositol-5-phosphate activation and conserved substrate specificity of the myotubularin phosphatidylinositol 3-phosphatases. Carr. Biol., 13, 504-509.
25. Sereda, M.W., Meyer zu Horste, G., Suter, U., Uzma, N. and Nave, K.A. (2003) Therapeutic administration of progesterone antagonist in a model of Charcot-Marie-Tooth disease (CMT-lA). Nat. Med., 9, 1533-1537.
26. Passage, E., Norreel, J.C., Noack-Fraissignes, P., Sanguedolce, V., Pizant, J., Thirion, X., Robaglia-Schlupp, A., Pellissier, J.F. and Fornes, M. (2004) Ascorbic acid treatment corrects the phenotype of a mouse model of Charcot-Marie-Tooth disease. Nat. Med., 10, 396-401.
27. Sahenk, Z., Nagaraja, H.N., McCracken, B.S., King, W.M., Freimer, M.L., Cedarbaum, J.M. and Mendell, JR. (2005) NT-3 promotes nerve regeneration and sensory improvement in CMT1A mouse models and in patients. Neurology, 65, 681-689.
28. Martini, R. and Toyka, K.V. (2004) Immune-mediated components of hereditary demyelinating neuropathies: Lessons from animal models and patients. Lancet Neural., 3, 457-465.
29. Benstead, T.J. and Grant, I.A. (2001) Progress in clinical neurosciences: Charcot-Marie-Tooth disease and related inherited peripheral neuropathies. Can. J Neural. Sci., 28, 199-214.
30. Kim, S.A., Taylor, G.S., Torgersen, K.M. and Dixon, J.E. (2002) Myotubularin and MTMR2, phosphatidylinositol 3-phosphatases mutated in myotubular myopathy and type 4B Charcot-Marie-Tooth disease. J Biol. Chem., 277, 4526-4531.
31. Parrish, W.R., Stefan, C.J. and Emr, S.D. (2004) Essential role for the myotubularin-related phosphatase Ymr1p and the synaptojanin-like phosphatases Sj12p and Sj13p in regulation of phosphatidylinositol 3-phosphate in yeast. Mol. Biol. Cell, 15, 3567-3579.
32. Xue, Y., Fares, H., Grant, B., Li, Z., Rose, A.M., Clark, S.G. and Skolnik, E.Y. (2003) Genetic analysis of the myotubularin family of phosphatases in Caenorhabditis elegans. J Biol. Chem., 278, 34380-34386.
33. Dang, H., Li, Z., Skolnik, E.Y. and Fares, H. (2004) Disease-related myotubularins function in endocytic traffic in Caenorhabditis elegans. Mol. Biol. Cell, 15, 189-196.
34. Tsujita, K., Itoh, T., Ijuin, T., Yamamoto, A., Shisheva, A., Laporte, J. and Takenawa, T. (2004) Myotubularin regulates the function of the late endosome through the GRAM domain-phosphatidylinositol 3,5-bisphosphate interaction. J Biol. Chem., 279, 13817-13824.
35. Lee, O.K., Frese, K.K., James, J.S., Chadda, D., Chen, Z.H., Javier, R.T. and Cho, K.O. (2003) Discs-large and strabismus are functionally linked to plasma membrane formation. Nat. Cell Biol., 5, 987-993.
36. Firestein, R., Nagy, P.L., Daly, M., Huie, P., Conti, M. and Cleary, M.L. (2002) Male infertility, impaired spermatogenesis, and azoospermia in mice deficient for the pseudophosphatase Sbf1. J Clin. Invest., 109, 1165-1172.
37. Schaeren-Wiemers, N., Bonnet, A., Erb, M., Erne, B., Bartsch, U., Kern, F., Mantei, N., Sherman, D. and Suter, U. (2004) The raft-associated protein MAL is required for maintenance of proper axon-glia interactions in the central nervous system. J Cell Biol., 166, 731-742.